Page 11 - JaKita 08st Edition 2021
P. 11
TOP REPORT 11 11
Head of Corporate Communication of
PT Bio Farma (Persero), Iwan Setiawan:
“Mild Side Effects of the
COVID-19 Vaccine”
COVID-19 through the provision of COVID-19
vaccines in Indonesia. The provision of vaccines is
in the form of finished and bulk vaccines which are
then filled and finished at Bio Farma.
In vaccine development, Indonesia is involved in
the third phase of the trial. What does it mean?
Phase 3 are clinical trials to see the safety and
efficacy of the product, with a larger sample size.
Clinical trials are an important stage in research
and development to obtain valid efficacy, safety
data to support the registration process and use of
the developed COVID-19 vaccine.
How is the process?
In Sinovac clinical trial, 1,620 people were involved
and their test results met the requirements, so
now the Sinovac vaccine can be used to overcome
COVID-19 pandemic.
What about the safety of this COVID-19 vaccine
in general?
iofarma has important role in the nation’s During the monitoring phase of clinical trials
vaccination program. This state-owned conducted in Indonesia, mild side effects of the
B(BUMN) pharmaceutical company has carried COVID-19 vaccine were found, such as pain at the
out a clinical trial process on vaccines used in injection site, muscle aches and fever. In general,
Indonesia. How safe is the COVID-19 vaccine? the fever is mild and will disappear in 1 to 3 days.
Read JaKita’s interview with the Head of Corporate
Communication of PT Bio Farma (Persero), Iwan Sinovac’s efficacy is 65 percent. What does it
Setiawan: mean?
Can you explain the role of Bio Farma in Vaccines with 65.3 percent efficacy in clinical
COVID-19 vaccination program? trials means there is a 65.3 percent reduction in
cases in the vaccinated group compared to the
Bio Farma is the Parent Holding BUMN unvaccinated group.
Pharmaceutical, which committed to handle sam
8th EDITION 2021
Sarana Informasi Pemerintah Provinsi DKI Jakarta
